Durham NC 结肠癌临床试验
12项针对 结肠癌的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Durham
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- The University of North Carolina At Chapel Hill, Chapel Hill · 距离 10 英里
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- UNC- Chapel Hill, Chapel Hill · 距离 10 英里
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
招募中2/3 期
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
Shield Post-Approval Study Protocol
招募中观察性研究欢迎健康志愿者
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
- University of North Carolina at Chapel Hill, Hillsborough · 距离 13 英里
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
招募中1 期
- Xencor Investigative Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Duke Cancer Center, Durham
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
招募中3 期
- GSK Investigational Site, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 距离 10 英里
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
招募中2 期
- University of North Carolina, Chapel Hill · 距离 10 英里
其他城市的 结肠癌试验
- Boston, MA22 项研究
- New York City, NY22 项研究
- Houston, TX20 项研究
- Los Angeles, CA16 项研究
- Nashville, TN16 项研究
- St. Louis, MO15 项研究
- Arlington, VA15 项研究
- Chicago, IL14 项研究
- San Antonio, TX14 项研究
- Baldwin Park, CA14 项研究
- Baltimore, MD13 项研究
- Tampa, FL13 项研究
Durham的其他研究
- 乳腺癌64 项研究
- 癌症(所有类型)58 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 急性髓系白血病33 项研究
- 转移性癌症33 项研究
- 前列腺癌32 项研究
- 肺癌32 项研究
- 结直肠癌28 项研究
- 卵巢癌27 项研究
- 慢性淋巴细胞白血病27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。